LU87437A1 - Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant - Google Patents

Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant Download PDF

Info

Publication number
LU87437A1
LU87437A1 LU87437A LU87437A LU87437A1 LU 87437 A1 LU87437 A1 LU 87437A1 LU 87437 A LU87437 A LU 87437A LU 87437 A LU87437 A LU 87437A LU 87437 A1 LU87437 A1 LU 87437A1
Authority
LU
Luxembourg
Prior art keywords
compound
formula
purine
compounds
pharmaceutically acceptable
Prior art date
Application number
LU87437A
Other languages
English (en)
French (fr)
Inventor
Vince Robert
Hua Mei Jla
Myers Peter Leslie
Storer Richard
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of LU87437A1 publication Critical patent/LU87437A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LU87437A 1988-01-20 1989-01-19 Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant LU87437A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US14625288 1988-01-20
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB8821011 1988-09-07
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US27865288 1988-12-05
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (1)

Publication Number Publication Date
LU87437A1 true LU87437A1 (fr) 1989-08-30

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87437A LU87437A1 (fr) 1988-01-20 1989-01-19 Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant

Country Status (29)

Country Link
JP (1) JP2793825B2 (xx)
KR (1) KR0127137B1 (xx)
AT (1) AT397801B (xx)
AU (2) AU626278B2 (xx)
BE (1) BE1003815A4 (xx)
CA (1) CA1339896C (xx)
CH (1) CH679152A5 (xx)
DE (1) DE3901502C2 (xx)
DK (1) DK175131B1 (xx)
ES (1) ES2010091A6 (xx)
FI (1) FI93546C (xx)
FR (1) FR2626002B1 (xx)
GB (1) GB2217320B (xx)
GR (1) GR890100033A (xx)
HU (1) HU203755B (xx)
IE (1) IE62275B1 (xx)
IL (1) IL88999A (xx)
IT (1) IT1229531B (xx)
LU (1) LU87437A1 (xx)
MY (1) MY103801A (xx)
NL (1) NL8900122A (xx)
NO (1) NO169123C (xx)
NZ (1) NZ227663A (xx)
OA (1) OA09031A (xx)
PL (1) PL163814B1 (xx)
PT (1) PT89482B (xx)
RU (1) RU2114846C1 (xx)
SE (1) SE505213C2 (xx)
YU (1) YU47791B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
ES2136061T3 (es) * 1989-06-27 1999-11-16 Wellcome Found Nucleosidos terapeuticos.
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
KR960705825A (ko) * 1993-11-12 1996-11-08 게리 디. 스트리트 면역억제제로서 유용한 6-옥소-뉴클레오시드(6-Oxo-nucleosides useful as immunosuppressants)
GB9721780D0 (en) 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
CN1115338C (zh) * 1998-10-30 2003-07-23 隆萨股份公司 4－[(2′,5′－二氨基－6′－卤代嘧啶－4′－基)氨基]－环戊－2－烯基甲醇的制备方法
KR100606625B1 (ko) 1998-10-30 2006-07-28 론자 아게 4-[(2',5'-디아미노-6'-할로피리미딘-4'-일)아미노]-시클로펜트-2-에닐메탄올의 제조 방법
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
EP3831388B1 (en) 2018-07-27 2024-02-28 FUJIFILM Corporation Cyclopentenyl purine derivative or salt thereof for use in suppressing adenovirus
WO2021191417A1 (en) 2020-03-27 2021-09-30 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (ja) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd 遠心紡糸によるカ−ボン繊維の製造装置
IN164556B (xx) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
DE3901502A1 (de) 1989-07-27
GB2217320A (en) 1989-10-25
ES2010091A6 (es) 1989-10-16
SE8900192L (sv) 1989-07-21
FI890286A0 (fi) 1989-01-19
JPH02196788A (ja) 1990-08-03
PL163814B1 (en) 1994-05-31
NL8900122A (nl) 1989-08-16
NO890253L (no) 1989-07-21
SE505213C2 (sv) 1997-07-14
KR890011902A (ko) 1989-08-23
YU47791B (sr) 1996-01-09
JP2793825B2 (ja) 1998-09-03
MY103801A (en) 1993-09-30
PT89482A (pt) 1989-10-04
OA09031A (en) 1991-03-31
YU12389A (en) 1991-10-31
NO169123C (no) 1992-05-13
AU637015B2 (en) 1993-05-13
PL277261A1 (en) 1989-09-18
PT89482B (pt) 1994-02-28
SE8900192D0 (sv) 1989-01-19
FI93546B (fi) 1995-01-13
HU203755B (en) 1991-09-30
IE62275B1 (en) 1995-01-25
AU2867189A (en) 1989-07-20
FI890286A (fi) 1989-07-21
DK23489A (da) 1989-07-21
AU1018092A (en) 1992-03-12
CA1339896C (en) 1998-06-02
GB2217320B (en) 1992-04-08
AU626278B2 (en) 1992-07-30
DK23489D0 (da) 1989-01-19
HUT48887A (en) 1989-07-28
FR2626002A1 (fr) 1989-07-21
NZ227663A (en) 1990-09-26
IT8947546A0 (it) 1989-01-19
AT397801B (de) 1994-07-25
IL88999A0 (en) 1989-08-15
IT1229531B (it) 1991-09-04
DE3901502C2 (de) 2002-06-13
CH679152A5 (xx) 1991-12-31
GB8901187D0 (en) 1989-03-15
NO169123B (no) 1992-02-03
IL88999A (en) 1994-12-29
DK175131B1 (da) 2004-06-14
KR0127137B1 (ko) 1997-12-29
FR2626002B1 (fr) 1994-01-28
ATA10689A (de) 1993-11-15
FI93546C (fi) 1995-04-25
GR890100033A (el) 1994-03-31
IE890153L (en) 1989-07-20
BE1003815A4 (fr) 1992-06-23
RU2114846C1 (ru) 1998-07-10
NO890253D0 (no) 1989-01-19

Similar Documents

Publication Publication Date Title
BE1003815A4 (fr) Nucleosides dideoxydidehydrocarbocyliques et composition pharmaceutique les contenant.
RU2126405C1 (ru) (-)-4-амино-5-фтор-1-(2-гидроксиметил-1,3-оксатиолан-5-ил)-(1h)-пиримидин- 2-он, смесь его энантиомеров, способы их получения, способ лечения
JP3421335B2 (ja) 鏡像異性的に純粋なβ−Ｄ−（−）−ジオキソラン−ヌクレオシド
AP91A (en) Dideoxydidehydrocarbocyclic nucleosides.
JP3117217B2 (ja) 選択的な抗Ｂ型肝炎ウイルス活性を有する鏡像体的に純粋なβ−Ｄ−ジオキソランヌクレオシド
FI111722B (fi) Menetelmä valmistaa cis-4-amino-1-(2-hydroksimetyyli-1,3-oksatiolan-5-yyli)-(1H)-pyrimidin-2-onin (-)-enantiomeeriä käytettäväksi virustenvastaisena aineena
JP4503206B2 (ja) エナンチオマー的に純粋なβ‐Ｄ‐ジオキソラン−ヌクレオシド
IE921601A1 (en) 1,3-oxathiolanes useful in the treatment of hepatitis
EP2406263B1 (fr) Derivés de pyrazolo[1,5-a]-1,3,5-triazines, leur preparation et leur application en thérapeutique
HU208134B (en) Process for producing substituted 1,3-oxathiolanes and pharmaceutical compositions comprising same
FR2585019A1 (fr) Derives de distamycine et leur procede de fabrication
FR2511679A1 (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent
HU207320B (en) Method for producing new n-heteroaryl-purine-6-amine derivatives and medical preparatives containing them
EP1095029A1 (fr) Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine
EP1353926B1 (fr) Derives de mikanolide, leur preparation et leurs applications therapeutiques
EP0699679A1 (fr) Nouveaux composés tétrahydropyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0437382A1 (fr) Nouveaux dérivés de la thymidine leur préparation et les compositions qui les contiennent
BE896797A (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments.
SI9110782A (sl) 1,3-oksatiolanski nukleozidni analogi